Cargando…
Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma
Mutations in the cornified cell envelope protein loricrin have been reported recently in some patients with Vohwinkel syndrome (VS) and progressive symmetric erythrokeratoderma (PSEK). To establish a causative relationship between loricrin mutations and these diseases, we have generated transgenic m...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192631/ https://www.ncbi.nlm.nih.gov/pubmed/11038186 |
_version_ | 1782147284429963264 |
---|---|
author | Suga, Yasushi Jarnik, Michal Attar, Paul S. Longley, Mary A. Bundman, Donnie Steven, Alasdair C. Koch, Peter J. Roop, Dennis R. |
author_facet | Suga, Yasushi Jarnik, Michal Attar, Paul S. Longley, Mary A. Bundman, Donnie Steven, Alasdair C. Koch, Peter J. Roop, Dennis R. |
author_sort | Suga, Yasushi |
collection | PubMed |
description | Mutations in the cornified cell envelope protein loricrin have been reported recently in some patients with Vohwinkel syndrome (VS) and progressive symmetric erythrokeratoderma (PSEK). To establish a causative relationship between loricrin mutations and these diseases, we have generated transgenic mice expressing a COOH-terminal truncated form of loricrin that is similar to the protein expressed in VS and PSEK patients. At birth, transgenic mice (ML.VS) exhibited erythrokeratoderma with an epidermal barrier dysfunction. 4 d after birth, high-expressing transgenic animals showed a generalized scaling of the skin, as well as a constricting band encircling the tail and, by day 7, a thickening of the footpads. Histologically, ML.VS transgenic mice also showed retention of nuclei in the stratum corneum, a characteristic feature of VS and PSEK. Immunofluorescence and immunoelectron microscopy showed the mutant loricrin protein in the nucleus and cytoplasm of epidermal keratinocytes, but did not detect the protein in the cornified cell envelope. Transfection experiments indicated that the COOH-terminal domain of the mutant loricrin contains a nuclear localization signal. To determine whether the ML.VS phenotype resulted from dominant-negative interference of the transgene with endogenous loricrin, we mated the ML.VS transgenics with loricrin knockout mice. A severe phenotype was observed in mice that lacked expression of wild-type loricrin. Since loricrin knockout mice are largely asymptomatic (Koch, P.K., P.A. de Viragh, E. Scharer, D. Bundman, M.A. Longley, J. Bickenbach, Y. Kawachi, Y. Suga, Z. Zhou, M. Huber, et al., J. Cell Biol. 151:389–400, this issue), this phenotype may be attributed to expression of the mutant form of loricrin. Thus, deposition of the mutant protein in the nucleus appears to interfere with late stages of epidermal differentiation, resulting in a VS-like phenotype. |
format | Text |
id | pubmed-2192631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21926312008-05-01 Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma Suga, Yasushi Jarnik, Michal Attar, Paul S. Longley, Mary A. Bundman, Donnie Steven, Alasdair C. Koch, Peter J. Roop, Dennis R. J Cell Biol Original Article Mutations in the cornified cell envelope protein loricrin have been reported recently in some patients with Vohwinkel syndrome (VS) and progressive symmetric erythrokeratoderma (PSEK). To establish a causative relationship between loricrin mutations and these diseases, we have generated transgenic mice expressing a COOH-terminal truncated form of loricrin that is similar to the protein expressed in VS and PSEK patients. At birth, transgenic mice (ML.VS) exhibited erythrokeratoderma with an epidermal barrier dysfunction. 4 d after birth, high-expressing transgenic animals showed a generalized scaling of the skin, as well as a constricting band encircling the tail and, by day 7, a thickening of the footpads. Histologically, ML.VS transgenic mice also showed retention of nuclei in the stratum corneum, a characteristic feature of VS and PSEK. Immunofluorescence and immunoelectron microscopy showed the mutant loricrin protein in the nucleus and cytoplasm of epidermal keratinocytes, but did not detect the protein in the cornified cell envelope. Transfection experiments indicated that the COOH-terminal domain of the mutant loricrin contains a nuclear localization signal. To determine whether the ML.VS phenotype resulted from dominant-negative interference of the transgene with endogenous loricrin, we mated the ML.VS transgenics with loricrin knockout mice. A severe phenotype was observed in mice that lacked expression of wild-type loricrin. Since loricrin knockout mice are largely asymptomatic (Koch, P.K., P.A. de Viragh, E. Scharer, D. Bundman, M.A. Longley, J. Bickenbach, Y. Kawachi, Y. Suga, Z. Zhou, M. Huber, et al., J. Cell Biol. 151:389–400, this issue), this phenotype may be attributed to expression of the mutant form of loricrin. Thus, deposition of the mutant protein in the nucleus appears to interfere with late stages of epidermal differentiation, resulting in a VS-like phenotype. The Rockefeller University Press 2000-10-16 /pmc/articles/PMC2192631/ /pubmed/11038186 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Original Article Suga, Yasushi Jarnik, Michal Attar, Paul S. Longley, Mary A. Bundman, Donnie Steven, Alasdair C. Koch, Peter J. Roop, Dennis R. Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma |
title | Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma |
title_full | Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma |
title_fullStr | Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma |
title_full_unstemmed | Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma |
title_short | Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma |
title_sort | transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, vohwinkel syndrome and progressive symmetric erythrokeratoderma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192631/ https://www.ncbi.nlm.nih.gov/pubmed/11038186 |
work_keys_str_mv | AT sugayasushi transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma AT jarnikmichal transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma AT attarpauls transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma AT longleymarya transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma AT bundmandonnie transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma AT stevenalasdairc transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma AT kochpeterj transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma AT roopdennisr transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma |